Farther Finance Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Farther Finance Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-91	Closed	-$1.12K	–	4456
2024 Q4	$1.12K	Hold	91	–	–	﹤0.01%	3209
2024 Q3	$1.04K	Sell	91 -360	-80%	-$3.61K	﹤0.01%	3233
2024 Q2	$3.21K	Buy	451 +374	+486%	+$2.86K	﹤0.01%	2597
2024 Q1	$494	Buy	77 +21	+38%	+$144	﹤0.01%	3024
2023 Q4	$364	Buy	+56	New	+$361	﹤0.01%	3080
2023 Q3	–	Sell	-15	Closed	-$210	–	2714
2023 Q2	$210	Buy	+15	New	+$256	﹤0.01%	2356

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's CDMO Position: Q1 2025 in Review

Farther Finance Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 91 shares — an estimated $1.12K sold.

Farther Finance Advisors first reported a position in CDMO in Q2 2023 and held it in 6 quarters. The position peaked at $3.21K in Q2 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Farther Finance Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Farther Finance Advisors sold 91 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.12K.
Farther Finance Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
Farther Finance Advisors's Avid Bioservices, Inc. Common Stock position peaked at $3.21K in Q2 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Farther Finance Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.